Atara Biotherapeutics, Inc. (ATRA)
NASDAQ: ATRA · Real-Time Price · USD
9.30
-0.51 (-5.20%)
May 13, 2026, 10:49 AM EDT - Market open
Atara Biotherapeutics Employees
Atara Biotherapeutics had 14 employees as of December 31, 2025. The number of employees decreased by 139 or -90.85% compared to the previous year.
Employees
14
Change
-139
Growth
-90.85%
Revenue / Employee
$1,652,786
Profits / Employee
-$676,214
Market Cap
79.16M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 14 | -139 | -90.85% |
| Sep 30, 2025 | 38 | -121 | -76.10% |
| Jun 30, 2025 | 38 | -127 | -76.97% |
| Mar 31, 2025 | 89 | -84 | -48.55% |
| Dec 31, 2024 | 153 | -72 | -32.00% |
| Sep 30, 2024 | 159 | -149 | -48.38% |
| Jun 30, 2024 | 165 | -152 | -47.95% |
| Mar 31, 2024 | 173 | -157 | -47.58% |
| Dec 31, 2023 | 225 | -109 | -32.63% |
| Sep 30, 2023 | 308 | -32 | -9.41% |
| Jun 30, 2023 | 317 | -117 | -26.96% |
| Mar 31, 2023 | 330 | -240 | -42.11% |
| Dec 31, 2022 | 334 | -244 | -42.21% |
| Sep 30, 2022 | 340 | -238 | -41.18% |
| Jun 30, 2022 | 434 | -124 | -22.22% |
| Mar 31, 2022 | 570 | 90 | 18.75% |
| Dec 31, 2021 | 578 | 141 | 32.27% |
| Sep 30, 2021 | 578 | 149 | 34.73% |
| Jun 30, 2021 | 558 | 133 | 31.29% |
| Mar 31, 2021 | 480 | 71 | 17.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Champions Oncology | 213 |
| Gossamer Bio | 162 |
| Adicet Bio | 102 |
| Acrivon Therapeutics | 76 |
| PolyPid | 75 |
| eXoZymes | 32 |
| MAIA Biotechnology | 13 |
| Rein Therapeutics | 10 |
ATRA News
- 17 hours ago - Atara Biotherapeutics reports Q1 EPS -29c, consensus -22c - TheFly
- 19 hours ago - Atara Biotherapeutics Announces First Quarter 2026 Financial Results and Operational Progress - Business Wire
- 5 days ago - Atara Biotherapeutics upgraded to Buy from Hold at Canaccord - TheFly
- 5 days ago - Atara Biotherapeutics trading halted, volatility trading pause - TheFly
- 5 days ago - Atara Biotherapeutics jumps 70%, or $3.60, to $8.75 - TheFly
- 5 days ago - Atara Biotherapeutics trading resumes - TheFly
- 6 days ago - Atara says PFP had productive meeting with FDA - TheFly
- 6 days ago - Why Is Atara Biotherapeutics Stock (ATRA) Up Today? - TipRanks